Texas Sues Tylenol Makers Over Claims of Link to Autism

The lawsuit, led by Ken Paxton, the Republican attorney general of Texas, claims that the companies knowingly withheld evidence about Tylenol's potential links to autism and attention deficit hyperactivity disorder (ADHD). President Trump's recent comments linking Tylenol use during pregnancy to autism have drawn attention to the issue, with some following the lead of Robert F. Kennedy Jr., the nation's top health official.

The Texas lawsuit is the first state-level action that pursues Trump's allegations that acetaminophen products like Tylenol during pregnancy could cause neurodevelopmental disorders. Kenvue, the spinoff company that now owns Tylenol, has repeatedly defended the drug's safety and rejected Trump's claims. Ken Paxton's decision to file the case in a conservative, rural county near the Louisiana border may have been a strategic move to find a court sympathetic to his case.

Key Takeaways:

• The lawsuit claims that Johnson & Johnson and Kenvue knowingly withheld evidence about Tylenol's potential links to autism and ADHD.
• President Trump's recent comments linking Tylenol use during pregnancy to autism have sparked debate on the issue.
• Kenvue has defended Tylenol's safety, but the company is facing mounting lawsuits from families who claim that their children were diagnosed with autism or ADHD after taking Tylenol during pregnancy.
• Hundreds of lawsuits have been filed in recent years, but a U.S. judge in New York dismissed a large group of cases citing a lack of reliable scientific evidence.
• The most recent scientific review found evidence of a link between acetaminophen use during pregnancy and the development of autism and ADHD in childhood, but scientists have cautioned that the studies do not prove causation.
• Johnson & Johnson has said that it acted responsibly in warning consumers about Tylenol's proven risk of liver damage when taken in excess.
• Kenvue claims that it opposed the Food and Drug Administration's (FDA) recent proposal to include a warning on the Tylenol label about the connection to neurodevelopmental disorders.

Statistics:

• More than half of the 46 studies included in a recent scientific review found a positive correlation between use of the drug during pregnancy and neurodevelopmental disorders in children.
• One major study of nearly 2.5 million children born in Sweden found that, when accounting for the mother's genetics, there was no association between acetaminophen and neurodevelopmental disorders.
• Over 200 lawsuits have been filed in recent years by families who claim that their children were diagnosed with autism or ADHD after taking Tylenol during pregnancy.
• In 2022, the number of Tylenol lawsuits picked up steam, with many families seeking damages for alleged harm caused by the drug.
• Johnson & Johnson announced the spinoff of its consumer health business in 2021, with the split finalized in 2023.

Sources:

• "New York Times" article on the Texas lawsuit, citing Ken Paxton's statement on the case.
• "The Washington Post" article on the scientific review and its findings.
• "Kenvue" press release defending the safety of Tylenol and rejecting President Trump's claims.
• "Johnson & Johnson" statement on the company's handling of Tylenol lawsuits.
• "The Food and Drug Administration" (FDA) proposal to include a warning on the Tylenol label.
• "Robert F. Kennedy Jr." statement on the connection between acetaminophen and neurodevelopmental disorders.